Skip to main navigation Skip to search Skip to main content

New Ewing Sarcoma Research from National Cancer Institute (NCI) Outlined (Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor response)

  • William Figg

Press/Media

Period13 Nov 2024

Media coverage

1

Media coverage

  • TitleNew Ewing Sarcoma Research from National Cancer Institute (NCI) Outlined (Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor response)
    Media name/outletNewsRx Drug Daily
    Country/TerritoryUnited States
    Date13/11/24
    PersonsWilliam Figg